Targeting Anhedonia: Can Precision Dopamine Therapy Transform the Treatment of Depression?
Moving Beyond Depression as a Single Disease Major depressive disorder is often treated as a single condition, yet every clinician recognizes that no two patients experience depression in the same way. Some struggle primarily with sadness, others with anxiety, insomnia,…
How Electroconvulsive Therapy May Reset the Adult Brain: New Research Reveals Cellular Reprogramming and Circuit Remodeling
ECT Works Remarkably Well—but why? Electroconvulsive therapy (ECT) remains the most effective acute treatment for severe depression, psychotic depression, catatonia, and many cases of treatment-resistant depression. Its clinical benefits can be rapid, profound, and, with appropriate continuation treatment, durable. Yet…
Personalized Brain Mapping Improves Accelerated TMS Outcomes: Another Step Toward Precision Psychiatry
A New Era of Precision Neuromodulation Transcranial magnetic stimulation (TMS) has become one of the most important noninvasive treatments for patients with treatment-resistant depression (TRD). Yet, despite remarkable technological advances, one fundamental aspect of treatment has remained largely unchanged for…
Catatonia Revisited: Toward a New Systems Model of Brain Dysfunction
Catatonia Is More Than a Psychiatric Syndrome For over a century, catatonia has often been viewed through the lens of schizophrenia. Although this historical perspective shaped psychiatric practice for decades, modern evidence tells a different story. Today, catatonia is recognized…
MeRT® Receives FDA Clearance for PTSD: A New Step Toward Personalized Neuromodulation
A New Milestone for Personalized Brain Stimulation Neuromodulation continues to evolve at an extraordinary pace. While repetitive transcranial magnetic stimulation (TMS) has become an established treatment for major depressive disorder, investigators have long sought ways to make brain stimulation more…
When Two Failed Antidepressants Are Not Enough: Rethinking Treatment-Resistant Depression
Are We Defining Treatment-Resistant Depression Correctly? Treatment-resistant depression (TRD) affects millions of people worldwide and represents one of the greatest challenges in modern psychiatry. Patients with TRD experience greater disability, poorer quality of life, higher healthcare utilization, and substantially increased…
A New Brain–Computer Interface for Treatment-Resistant Depression: The Next Frontier in Interventional Psychiatry?
From Neuromodulation to Neurotechnology Over the past two decades, psychiatry has witnessed remarkable advances in neuromodulation. Treatments such as transcranial magnetic stimulation (TMS), electroconvulsive therapy (ECT), vagus nerve stimulation (VNS), and deep brain stimulation (DBS) have transformed the care of…
Deep Brain Stimulation May Rewire the Brain: New Evidence of White Matter Remodeling
For years, clinicians have observed a fascinating phenomenon in patients receiving deep-brain stimulation (DBS) for treatment-resistant depression. While some changes occur rapidly, the full antidepressant benefits often emerge gradually over weeks or months. Why does this happen? A groundbreaking study…
Focused Ultrasound for Psychiatric Disorders: A New Frontier in Incisionless Neurosurgery
Can Neurosurgery Be Performed Without an Incision? For decades, the idea of psychiatric neurosurgery has been met with both hope and hesitation. While procedures targeting specific brain circuits can provide meaningful relief for individuals with severe, treatment-resistant psychiatric disorders, traditional…
New Review Highlights the Emerging Role of the Microbiota–Gut–Brain Axis in Depression
Why Do Some Patients Remain Depressed Despite Multiple Treatments? One of the greatest challenges in psychiatry is treatment-resistant depression (TRD). Although many individuals with major depressive disorder respond to antidepressants, approximately one-third continue to experience significant symptoms despite multiple treatment…